THAR vs CEP
Comparison between Tharimmune Inc (THAR, Company) and Cantor Equity Partners Inc - Class A (CEP, Company).
THAR is from the Healthcare sector, while CEP is from the Financial Services sector.
THAR vs CEP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
THAR vs CEP - Historical Returns
Returns include dividend reinvestment.
THAR vs CEP - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | THAR | CEP |
|---|---|---|
| 2026 | -29.88% | +0.00% |
| 2025 | +47.80% | +37.34% |
| 2024 | -73.20% | +3.80% |
| 2023 | -94.03% | N/A |
| 2022 | -88.80% | N/A |
THAR vs CEP Drawdown Comparison
The maximum drawdown for THAR was -99.93%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for CEP was -77.58%, occurring on Dec 1, 2025. This drawdown has not yet recovered.
The current THAR drawdown is -99.85%. The current CEP drawdown is -71.46%.
| Rank | THAR | CEP |
|---|---|---|
| #1 | -99.93% Feb 2, 2022 - Apr 9, 2025 | -77.58% May 1, 2025 - Dec 1, 2025 |
| #2 | -26.15% Jan 12, 2022 - Jan 24, 2022 | -3.40% Dec 23, 2024 - Mar 26, 2025 |
| #3 | -2.13% Jan 24, 2022 - Jan 27, 2022 | -1.85% Apr 10, 2025 - Apr 23, 2025 |
| #4 | -1.87% Jan 31, 2022 - Feb 2, 2022 | -1.40% Apr 25, 2025 - Apr 29, 2025 |
| #5 | N/A | -1.27% Dec 16, 2024 - Dec 23, 2024 |
| #6 | N/A | -0.87% Nov 20, 2024 - Dec 2, 2024 |
| #7 | N/A | -0.74% Apr 1, 2025 - Apr 10, 2025 |
| #8 | N/A | -0.58% Dec 2, 2024 - Dec 12, 2024 |
| #9 | N/A | -0.40% Oct 25, 2024 - Nov 8, 2024 |
| #10 | N/A | -0.32% Aug 22, 2024 - Sep 24, 2024 |
| #11 | N/A | -0.20% Aug 13, 2024 - Aug 21, 2024 |
| #12 | N/A | -0.20% Sep 24, 2024 - Oct 21, 2024 |
| #13 | N/A | -0.20% Oct 21, 2024 - Oct 25, 2024 |
| #14 | N/A | -0.10% Nov 18, 2024 - Nov 20, 2024 |
| #15 | N/A | -0.10% Dec 12, 2024 - Dec 16, 2024 |
Correlation
Correlation between THAR and CEP is -0.12 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks